Literature DB >> 18539439

Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects.

David P Gavin, Saritha Kartan, Kayla Chase, Dennis R Grayson, Rajiv P Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18539439      PMCID： PMC3641902          DOI： 10.1016/j.schres.2008.04.026

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  9 in total

Review 1.  Histone modifications in transcriptional regulation.

Authors:  Shelley L Berger
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

Review 2.  The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis.

Authors:  Arturas Petronis
Journal:  Biol Psychiatry       Date:  2004-05-15       Impact factor: 13.382

3.  Epigenetic differences arise during the lifetime of monozygotic twins.

Authors:  Mario F Fraga; Esteban Ballestar; Maria F Paz; Santiago Ropero; Fernando Setien; Maria L Ballestar; Damia Heine-Suñer; Juan C Cigudosa; Miguel Urioste; Javier Benitez; Manuel Boix-Chornet; Abel Sanchez-Aguilera; Charlotte Ling; Emma Carlsson; Pernille Poulsen; Allan Vaag; Zarko Stephan; Tim D Spector; Yue-Zhong Wu; Christoph Plass; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

4.  Evaluating the comparability of gene expression in blood and brain.

Authors:  Patrick F Sullivan; Cheng Fan; Charles M Perou
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-04-05       Impact factor: 3.568

5.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.

Authors:  M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

6.  Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population.

Authors:  Rajiv P Sharma; Cherise Rosen; Saritha Kartan; Alessandro Guidotti; Erminio Costa; Dennis R Grayson; Kayla Chase
Journal:  Schizophr Res       Date:  2006-09-25       Impact factor: 4.939

Review 7.  Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics.

Authors:  Rajiv P Sharma
Journal:  Schizophr Res       Date:  2005-01-01       Impact factor: 4.939

Review 8.  REELIN and schizophrenia: a disease at the interface of the genome and the epigenome.

Authors:  E Costa; Y Chen; J Davis; E Dong; J S Noh; L Tremolizzo; M Veldic; D R Grayson; A Guidotti
Journal:  Mol Interv       Date:  2002-02

9.  GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia.

Authors:  Hsien-Sung Huang; Schahram Akbarian
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240
  9 in total
  19 in total

1.  Epigenetics in the human brain.

Authors:  Isaac Houston; Cyril J Peter; Amanda Mitchell; Juerg Straubhaar; Evgeny Rogaev; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2012-05-30       Impact factor: 7.853

2.  Evidence of a sex-dependent restrictive epigenome in schizophrenia.

Authors:  Kayla A Chase; Cherise Rosen; Leah H Rubin; Benjamin Feiner; Anjuli S Bodapati; Hannah Gin; Edward Hu; Rajiv P Sharma
Journal:  J Psychiatr Res       Date:  2015-04-18       Impact factor: 4.791

Review 3.  Histone modifications, DNA methylation, and schizophrenia.

Authors:  David P Gavin; Rajiv P Sharma
Journal:  Neurosci Biobehav Rev       Date:  2009-10-30       Impact factor: 8.989

4.  Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia.

Authors:  David P Gavin; Rajiv P Sharma
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-07-22

Review 5.  Epigenetic Factors in Schizophrenia: Mechanisms and Experimental Approaches.

Authors:  Melanie Föcking; Benjamin Doyle; Nayla Munawar; Eugene T Dillon; David Cotter; Gerard Cagney
Journal:  Mol Neuropsychiatry       Date:  2019-02-15

Review 6.  Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.

Authors:  Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02-05       Impact factor: 5.270

Review 7.  Active DNA demethylation in post-mitotic neurons: a reason for optimism.

Authors:  David P Gavin; Kayla A Chase; Rajiv P Sharma
Journal:  Neuropharmacology       Date:  2013-08-16       Impact factor: 5.250

8.  Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis.

Authors:  David P Gavin; Rajiv P Sharma; Kayla A Chase; Francesco Matrisciano; Erbo Dong; Alessandro Guidotti
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

9.  Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures.

Authors:  David P Gavin; Cherise Rosen; Kayla Chase; Dennis R Grayson; Nguwah Tun; Rajiv P Sharma
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

Review 10.  Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions.

Authors:  Sama F Sleiman; Manuela Basso; Lata Mahishi; Alan P Kozikowski; Mary E Donohoe; Brett Langley; Rajiv R Ratan
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.